earnings
EI
NASDAQ · EIKN
Eikon Therapeutics, Inc.
Public company research
$8.51
Up+$0.15 (+1.70%)
Updated Sep 17, 2026, 7:20 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- —
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- $7.90 – $15.78
- Volume
- 989.38K
- Avg. volume
- —
Price performance
EIKN price history
1M range · 20 trading sessions · Daily adjusted prices
EIKN closed at $8.51 after 20 trading sessions, down 29.14% for the selected period.
- Last close
- $8.51
- Period change
- -29.14%
- Period low
- $8.51
- Period high
- $12.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $9.47 | $9.6388 | $8.39 | $8.51 | 989.38K |
| Sep 15, 2026 | $9.33 | $10.24 | $9.075 | $9.49 | 843.45K |
| Sep 14, 2026 | $8.95 | $9.44 | $8.93 | $9.36 | 713.12K |
| Sep 11, 2026 | $9.28 | $9.56 | $8.79 | $8.94 | 1.01M |
| Sep 10, 2026 | $10.65 | $10.68 | $9.17 | $9.21 | 665.09K |
| Sep 9, 2026 | $11.01 | $11.47 | $10.63 | $10.73 | 752.41K |
| Sep 8, 2026 | $10.81 | $11.03 | $10.61 | $10.71 | 464.89K |
| Sep 4, 2026 | $10.81 | $11.05 | $10.62 | $10.86 | 238.7K |
| Sep 3, 2026 | $11.45 | $11.66 | $10.91 | $10.96 | 384.28K |
| Sep 2, 2026 | $10.91 | $11.67 | $10.65 | $11.38 | 553.42K |
| Sep 1, 2026 | $10.31 | $10.94 | $10.10 | $10.88 | 333.49K |
| Aug 31, 2026 | $10.89 | $10.91 | $10.45 | $10.46 | 290.73K |
| Aug 28, 2026 | $11.41 | $11.45 | $10.90 | $10.98 | 239.64K |
| Aug 27, 2026 | $11.97 | $12.235 | $11.46 | $11.52 | 261.66K |
| Aug 26, 2026 | $12.56 | $13.00 | $11.90 | $11.98 | 324.09K |
| Aug 25, 2026 | $11.26 | $12.82 | $11.24 | $12.55 | 567.2K |
| Aug 24, 2026 | $11.59 | $11.92 | $10.94 | $11.16 | 398.36K |
| Aug 21, 2026 | $10.87 | $12.11 | $10.75 | $11.39 | 532.8K |
| Aug 20, 2026 | $11.90 | $12.04 | $10.40 | $10.75 | 559.73K |
| Aug 19, 2026 | $12.77 | $14.509 | $11.74 | $12.01 | 1.41M |
Latest EIKN news
The latest Smart Investors Daily articles mentioning EIKN.
Stock researchCompany · Financials
Loading stock research…